D. Henry, N. Dahl and on Behalf of the Ferrleict Cancer Study Group, “Iron or Vitamin B12 Deficiency in Anemic Patients Prior to Erythropoiesis-Stimulating Agent Therapy,” Community Oncology, Vol. 4, No. 2, 2007, pp. 95-101. doi:10.1016/S1548-5315(11)70057-2

has been cited by the following article:

• TITLE: Iron-Restricted Erythropoiesis in a Population of Elderly Hospitalized Anemic Patients

  AUTHORS: Torbjörn Karlsson

  KEYWORDS: Anemia; Iron-Restriction; Elderly Patients

  JOURNAL NAME: Open Journal of Blood Diseases, Vol.2 No.2, June 25, 2012

  ABSTRACT: The aim of this observational study was to assess the prevalence of iron-restricted erythropoiesis (IRE) in a population of elderly hospitalized anemic patients. Prevalence of IRE was found to be 41% and the most common clinical diagnoses in such patients were hematologic malignancies and solid tumors. Comparison between patients with IRE and non-IRE patients revealed that mean corpuscular volume, mean corpuscular hemoglobin, iron, and transferrin saturation were significantly lower in the IRE group, whereas no significant difference was found for Hb, transferrin, or ferritin. There was a more pronounced inflammatory response in the IRE group demonstrated by a higher C-reactive protein level.